verosudil   Click here for help

GtoPdb Ligand ID: 8911

Synonyms: AR 12286 | AR-12286
Compound class: Synthetic organic
Comment: Verosudil is an investigational Rho kinase inhibitor.
The INN record for verosudil indicates that this is a racemic mixture. We show the chemical structure without stereochemistry to represent the mixture. The (2S)-isomer is represented in PubChem CID 86270580 and the (2R)-isomer is represented in CID 44198631.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 5
Topological polar surface area 93.44
Molecular weight 327.1
XLogP 1.83
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN(C(c1cscc1)C(=O)Nc1ccc2c(c1)cc[nH]c2=O)C
Isomeric SMILES CN(C(c1cscc1)C(=O)Nc1ccc2c(c1)cc[nH]c2=O)C
InChI InChI=1S/C17H17N3O2S/c1-20(2)15(12-6-8-23-10-12)17(22)19-13-3-4-14-11(9-13)5-7-18-16(14)21/h3-10,15H,1-2H3,(H,18,21)(H,19,22)
InChI Key VDYRZXYYQMMFJW-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Verosudil is being evaluated in Phase II clinical trial for its potential to reduce intraocular pressure in patients diagnosed with ocular hypertension or glaucoma [1]. Click here to link to ClinicalTrials.gov's listing of AR-12286 trials.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Non-human primate studies suggest that AR-12286 lowers intraocular pressure primarily by increasing aqueous humor outflow through the trabecular meshwork, as do other Rho kinase inhibitors such as fasudil and Y27632.